GCP source data: access and control at the investigator site
For GCP source data at a trial site, an investigator needs appropriate access to relevant information during the trial and arrangements for required records afterwards. A sponsor portal can provide access while leaving control of the data unresolved. A worked example connects ongoing access, blinding and the eventual handover.
How can the investigator site retain the required access to and control over source data?
Define which source data and essential records the investigator site needs, who controls them and how they remain available during and after the trial. Relevant data must not be solely under sponsor control. Plan suitable independent copies or justified alternative controls, plus a complete, understandable handover. Give the site enough opportunity to review the data before access is withdrawn. Assess blinding and applicable retention requirements separately.
Access and actual data control differ.
Determine the required content and blinding limits prior to handover.
Connect account closure with verified, usable transition.
1. Assign source data to the study context
The article concerns clinical trials of human medicines. ICH E6(R3) Annex 1 addresses investigator records and responsibilities, data and computerised systems. The 2023 EMA guideline gives further detail on electronic systems and trial site access to data.
Principles and Annex 1 are effective in the EU from 23 July 2025. Annex 2 will become effective according to the current EMA status on 15 January 2027. For the access scenario discussed herein, the already effective foundations are applied. A general transfer of GMP Annex 11 requirements or a blanket retention period to all study data does not apply.
Document pre-emptively identify the source data that arise, where they are recorded, and how they are accessible. This may include internal records, central laboratory results, or data directly entered by participants. Particular relevance lies in determining which information influences the assessment of suitability, treatment, or safety.
Not every party requires unrestricted access to all study data. Blinding and protocol-based exceptions must be considered. Therefore, an access concept should clearly define which user receives which information at any given time. The necessary control over one's own and key records must not be substituted by a general reference to the sponsor portal.
A login may work temporarily while the trial site lacks sufficient control over its records. The EMA guideline addresses the risk of relevant source data being solely under sponsor control. Use suitable independent copies or justified technical alternatives to prevent that situation.
The internal matrix serves as a basis for evaluating a specific model. It is not a rule mandating that every file must always be dynamic or immutable. What is essential are content, meaning, required metadata, availability, and justified control throughout the relevant period.
Own work matrix for data access and control
Situation
What a login alone does not clarify
Coordinated Control
Ongoing data capture
Can the Sponsor control the data exclusively or arbitrarily revoke access?
Appropriate independent data source or justified alternative measures
Central Laboratory
Does the investigator receive relevant findings in time?
Immediate access in accordance with the protocol
Blind information
Which contents may still not be visible?
Roll and time-based access restriction
Read-only Phase
Are changes, relevant history, and context understandable?
Required data view and subsequent batch release determination
After study completion
Is recording retained usable without active service access?
Appropriate handover, review and continued retention
ICH E6(R3) specifies the need for the investigator to have timely access to relevant data, including data from external sources. This is particularly important when information may affect participant confidentiality or safety. A subsequent archive copy does not resolve an existing access gap that existed during the study.
Therefore, also plan to deal with failures, blocked accounts and changes of employees. The concrete solution depends on the system and the importance of the data. A replacement route does not have to replicate all comfort functions, but should allow the necessary action. Data protection and blinding remain to be observed even in the event of a malfunction; an uncontrolled common account would not be an appropriate standard solution.
At close-out, a trial site expects a copy of the records for twelve participants. The agreed scope includes the relevant electronic data entered, subsequent changes and required attachments. The check finds twelve participant folders, but one is missing a relevant laboratory attachment. The folder count alone cannot establish completeness.
The site also verifies whether it can access and assign the data without the previous portal access. The table describes an individual intended workflow. It does not establish a universal export format for all studies.
Example: completed handover matrix
Step
Find or specified condition
Decision
Evidence needed
Compare contents
12 participant order books available; 1 relevant annex is missing
Handover is still incomplete
Identify and supplement missing content
Verify assignment
The attachment must belong to the correct participant and timing.
File name alone is not sufficient
Control content and context
Assess usability
Release at intended work location without opening the portal
Assess readability and required context
Result of practical testing
End access
Investigation of complete release documentation still open
Keep access in place until the review is complete
Approved transfer following an appropriate procedure
Ongoing operation
Storage responsibility and access rights regulated upon handover
Maintain required availability
Accountability and appropriate storage documentation
A PDF file may be suitable for certain information. However, it is not automatically a complete copy of all required electronic information. Assess which data, relevant history, metadata, and relationships are needed. Conversely, every output does not need to replicate all functions of the original system.
Before withdrawing read-only access, the EMA guideline describes providing a complete, understandable copy of the required data, including the relevant audit trail context. The trial site should not need advanced technical skills to use it. Agree the format and test usability before shutdown.
7. Explicitly control exit and transition procedures
The agreements should clarify which party provides each deliverable and ensure that the investigator site maintains control over the monitoring. For data hosted by providers, an appropriate transfer procedure must be established; the EMA explicitly excludes exclusive sponsor control. A change of provider or termination of the contract shall not trigger this issue.
Plan for a change of responsible person or institution. ICH E6(R3) addresses control and retention of essential records and communication of changes to those arrangements. Determine the retention period from the applicable framework and the responsibilities agreed for those records. A single period for every type of data would be too imprecise.
The transition is considered complete when the required data are available in an appropriate format, their use has been reviewed, and subsequent responsibilities are clearly defined. A shipping confirmation for a download link alone does not constitute evidence of this. Similarly, the number of folders does not substitute for verification that each contains the required contents.
The following internal assistance document can help structure the closing phase. It leaves the study-specific data selection open, while requiring a clear decision on that matter. Thus, ongoing access and subsequent retention are treated as a continuous process.
Data source types, storage locations, and responsible parties defined.
External relevant data made available in a timely manner.
Blind spots and roles in the access concept are considered.
Exclusive sponsor control effectively avoided.
Required output including context and history agreed.
Completeness, assignment, and practical usability verified.
Account closure and further responsibilities are only traceable thereafter.
With study owners and the system team, we identify the data the investigator site needs during the trial and the records it must retain afterwards. Controlled examples test access, blinding, complete handover and later retrieval. An appropriate independent dataset may need a different technical solution from an active portal. Before access ends, we support acceptance of the content handed over. A successful download does not establish completeness.
Frequently asked questions about GCP source data access and control at the investigator site
Is an active portal access available for data control?+
Not automatically. A login is a means of access. The trial site must retain the required control and availability of its records. Check whether the sponsor alone controls the data and what happens when access is withdrawn.
Can the inspection site have access to all study data?+
No. Access is based on responsibilities, relevant data, and the protocol. Blinding may limit certain information. However, the required data for participant monitoring, safety, and own records must remain available in an appropriate manner.
Are central laboratory test results also relevant?+
Yes, if they are important for the assessment of suitability, treatment, or safety and for the required evidence. ICH E6(R3) considers timely access to relevant external data. A copy provided only after study completion cannot substitute for this ongoing need.
No. A static copy may suffice for static content if it preserves the required information, including context, content and structure. For dynamic files, the EMA calls for the dynamic properties of the original to be captured as well (2023 guideline, section 6.5). Test what the trial site will later need to understand and reconstruct for the actual data type.
Is PDF automatically an appropriate complete copy?+
No. Verify that the required data, relationships, and relevant changes are clearly included. A concise PDF report may omit essential detail information. The format alone does not guarantee completeness or sufficient future usability.
The EMA guideline combines withdrawal with a pre-provided complete, understandable copy and sufficient time for testing it. Access should not be withdrawn before completion of this review. Plan content, format and acceptance therefore before the shutdown date.
Why are twelve participant logs insufficient in the example of this article?+
The number indicates only that twelve folders are present. A relevant annex may still be missing or incorrectly assigned. The reconciliation must verify the agreed-upon required contents and their interrelationships. Quantity and content control address different questions.
The EMA guideline limits control over relevant source data to the sponsor alone. Appropriate independent copies or justified alternative technical measures should be considered. The specific solution must be documented and actually enable the required level of control.
Does a general retention period of 25 years apply to all data?+
No. The 25 years do not apply to all data. For a clinical trial of a human medicine within Regulation (EU) No. 536/2014, Article 58 requires the investigator and sponsor to retain the contents of their trial master files for at least 25 years after the trial ends, unless other Union law requires longer. National law governs patient medical files. Classify the records before determining the retention period.
Who should perform the practical handover verification?+
Involve people who can assess the content and how it will be used later. Technical support can assist. Define responsibilities in the applicable procedure. A successful download does not establish that the trial site can use its required records.
Source date: 7 October 2026. Regulatory requirements, guidelines, and industry practices must be categorized separately. Tables, figures, and case examples are to be considered standalone reference materials; they do not constitute completed product testing.
We support the investigational site, sponsor, and IT in planning specific data access, required controls, and a practical transition following study completion.
Bring your GxP systems into validated operation, from laboratory software, MES and eQMS to ERP. We define the scope, plan risk-based tests using GAMP 5 and hand the evidence to QA for release.
VAT identification number pursuant to § 27a German VAT Act (UStG): DE328451232
Consumer dispute resolution (VSBG)
In accordance with § 36 VSBG: we are neither willing nor obliged to participate in dispute resolution proceedings before a consumer arbitration board.
Liability for content
We are responsible for our own content on these pages under the general laws. Under Articles 4 to 8 of Regulation (EU) 2022/2065 (Digital Services Act, DSA), as a service provider we are not obliged to monitor transmitted or stored third-party information or to investigate circumstances that indicate unlawful activity.
Note: The §§ 7–10 of the previous Telemedia Act (TMG) on the liability for digital services have not been transferred to the German Digital Services Act (DDG). Liability for digital services is now primarily regulated by Regulation (EU) 2022/2065 (DSA), in particular Articles 4–8 — referenced above. The §§ 7–10 DDG cover other subjects (limited responsibility under DSA Articles 4–8 + Wi-Fi access, blocking claims under copyright law, lists of audiovisual-media-service and video-sharing-platform providers, and information-request rights of the competent authorities under state law).
Copyright
The content and works on these pages created by the site operator are subject to German copyright law. Reproduction, processing, distribution and any kind of exploitation outside the limits of copyright require the written consent of the respective author.
Privacy Policy
1. At a glance
The following information gives a simple overview of what happens to your personal data when you visit this website. Personal data is any data that can be used to identify you personally.
2. Controller
The controller responsible for data processing on this website pursuant to Art. 4 (7) GDPR is:
Daniel Herrmann Consulting Daniel Herrmann (sole proprietor) Enzweilerweg 3a · 66709 Weiskirchen · Germany Phone: +49 170 7878065 Email: info@daniel-herrmann.io
A data protection officer has not been appointed; the controller is your point of contact for all data protection matters.
3. Server logs
Our website is hosted by Kinsta Inc., 8605 Santa Monica Blvd #92581, West Hollywood, CA 90069, USA. When you visit, Kinsta processes your IP address, the time of the request, the page requested, the referring page and browser information. This helps keep the site secure and diagnose faults (Article 6(1)(f) GDPR). The site is hosted in Frankfurt, Germany. Kinsta keeps server logs for up to four days. It also analyses access log data, including IP addresses, in the US to operate and secure its services. It keeps this analytics data for up to 30 days. Kinsta’s data processing addendum includes the EU standard contractual clauses.
3a. Cookie-free page request counts
We count page requests using a small image served by this website. Each request increments a counter for the UTC day and page path. The counter stores no IP addresses, user agents, referrers, query parameters or visitor identifiers, sets no cookies and reads no browser storage. Known automated requests and prefetches are filtered using request headers without storing those headers. Counts include repeated loads and requests without statistics consent; they cannot identify individual visitors or measure their time on the site. Aggregates are removed after 90 days. Technical hosting logs are separate, as described above. The purpose is to understand the use of our public pages; the legal basis for the technical request processing is our legitimate interest under Art. 6(1)(f) GDPR in a data-minimising usage overview.
4. Contact
If you contact us via form, email or phone, we store the information you provide (name, email, telephone number, company, message content) to process the enquiry and for follow-up questions. Legal basis: Art. 6 (1) (b) GDPR (pre-contractual measures) and Art. 6 (1) (f) GDPR (legitimate interest in answering enquiries). Retention: deletion as soon as the enquiry has been finally processed, at the latest after 12 months, unless statutory retention obligations apply.
Our English project enquiry form emails your details to our team. It asks about your role, company size, the support you need and your timeframe. We do not send these enquiries to Calendly.
5. Practical guides and worksheets
For our other practical guides (e.g. Strategy Guide, Compliance-Gap Analysis, Execution Playbook), we ask for your name and email address. Your company is optional. The data is stored solely to provide the requested material and for documentation of consent. Legal basis: Art. 6 (1) (a) GDPR (consent). Retention: until your withdrawal, at most 24 months. The newsletter subscription is offered as a separate, opt-in checkbox on the lead-magnet form (no coupling — you can request the material without subscribing). No marketing emails are sent without separate consent.
For the GAMP 5 practice package, name, company, business email address and telephone number are required. We use these details to process your business enquiry, make the short telephone call you requested and personally send the documents afterwards. There is no automatic download in this process. The information under Contact applies to handling this enquiry. A newsletter subscription remains separate and optional.
The same manual enquiry process applies to the German worksheet packages on Annex 22, CSV project planning, CSA/CSV, Annex 11 and ALCOA+. Name, company, business email and telephone number are required for the requested short call and personal delivery of the worksheets. The information under Contact applies. Submitting the form does not verify your affiliation with a company or your telephone number, does not provide an automatic PDF download and does not subscribe you to a newsletter. This worksheet notice was added on 26 October 2026.
5a. Newsletter (Double-Opt-In)
If you sign up for our newsletter, we use the double-opt-in procedure: after entering your email and name you receive a confirmation email with a verification link. Only after you click the link do we activate the subscription and document your consent. Data: email, name, consent timestamp, confirmation IP. Purpose: sending our monthly newsletter with practice insights, plus documentation of the consent process (Art. 7 (1) GDPR). Legal basis: Art. 6 (1) (a) GDPR (consent), § 7 (2) Nr. 2 UWG. Retention: for as long as your subscription is active; consent logs retained for 3 years after the end of the subscription as evidence in the event of complaints. Withdrawal: every newsletter contains a one-click unsubscribe link in the footer. Alternatively a short email to info@daniel-herrmann.io is sufficient. Processor: the newsletter is sent via our hosting provider's SMTP infrastructure; we currently do not use a third-party email-marketing tool. As soon as we transition to a dedicated newsletter-tool (e.g. Brevo), we will update this section and conclude an additional data-processing agreement.
5c. Link-click tracking in our emails
To understand which content in our lead-magnet emails and newsletter issues is actually useful, we route outbound links through an internal redirect endpoint (`/t/`). Each link in each send gets an aggregate click counter — but we do NOT store an identifier of the individual recipient, NO IP address and NO user agent. The data we keep is comparable to anonymous server logs (e.g.: ‘link X in send Y was clicked 42 times in total’). It does not allow us to infer who clicked. Therefore no separate consent or cookie banner is required (recital 26 GDPR — anonymous data, no personal-data processing per Art. 4 (1) GDPR). Legal basis for the redirect itself: Art. 6 (1) (f) GDPR (legitimate interest in measuring content effectiveness for our own communications). Legal pages (Impressum, Datenschutz) and the unsubscribe link are NEVER routed through the redirect, so the click behaviour on legally relevant links is never measured.
5b. Retention overview & justifications
A consolidated view of all retention periods with the rationale behind each one — the principle: minimal storage, clear purpose, documented basis.
Data categoryRetentionJustification
Server logsUp to 4 days for server logs and up to 30 days for analytics dataSite operation, security and troubleshooting. See section 3.
Contact enquiries12 monthsB2B sales cycle in pharma typically runs 6–9 months. 12 months covers follow-ups without unnecessary stockpiling. Statutory retention (e.g. § 257 HGB) only applies once a contract is concluded.
Lead magnetsup to 24 monthsUntil withdrawal of consent; 24-month cap covers documentation of consent (Art. 7 GDPR) and re-engagement cycle. Withdrawal at any time, deletion within 7 days of request.
Newsletter subscriptionactive subscription + 3 yrs consent logEmail + name only as long as the subscription is active. Consent log (timestamp + IP) retained 3 years to cover statutory limitation period (§ 195 BGB) for complaints under § 7 UWG.
Cookies (incl. analytics)30 min – 14 monthsPer-tool detailed in 6.9. GA4 capped at 14 months (the GA4 minimum, shorter possible only via property reset); all other tools below or equal to industry standard.
Cookiebot consent12 monthsMaximum window the EDPB considers reasonable for repeat-consent requests. After 12 months a fresh banner appears.
6. Cookies, analytics & tracking
This website uses analytics and tracking tools that go beyond pure reach measurement and create usage profiles. Personal data may be processed (in particular IP address, device and browser information, behaviour data) and transferred to third countries (including the USA). Legal basis is your consent pursuant to § 25 (1) TDDDG and Art. 6 (1) (a) GDPR. The consent is granted on first visit via our cookie banner and can be withdrawn at any time with effect for the future — see section 6.10 below. Withdrawal is as simple as granting consent (Art. 7 (3) GDPR); the lawfulness of processing carried out on the basis of consent prior to withdrawal remains unaffected.
6.0 Consent management (Cookiebot)
Provider: Cybot A/S, Havnegade 39, 1058 Copenhagen, Denmark (a Usercentrics company) — EU-based. Purpose: Cookiebot is the consent management platform (CMP) we use to document your consent in line with § 25 TDDDG and Art. 7 GDPR and to block analytics / tracking tools until you opt in. Data: Cookiebot stores a ‘CookieConsent’ cookie containing your consent state (categories, timestamp, anonymous identifier) and a server-side consent log. Retention: up to 12 months from the moment consent is given; renewed on each new visit after expiry. Legal basis: the processing of consent itself rests on Art. 6 (1) (c) GDPR (legal obligation to document consent). Third-country transfer: primary processing in the EU; sub-processors may include service providers outside the EEA under EU Standard Contractual Clauses. Data processing agreement: concluded with Cybot A/S. More info:Cookiebot Privacy Policy.
6.1 Google Analytics 4
Provider: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland (parent company: Google LLC, USA). Purpose: Tracking tool that goes beyond pure reach measurement. Google uses the collected data for the operation of GA4 and partly for its own purposes (no commissioned processing in the narrow sense for these purposes). Data: pseudonymous identifiers (client ID), IP address (shortened on EU server, see below), page views, dwell time, scroll depth, click events, device and browser information, approximate location (country / region from IP). Retention: up to 14 months for event-level data, then automatic deletion. IP shortening: The IP address is shortened on an EU server before being forwarded to the USA (‘_anonymizeIp’ equivalent in GA4 is active by default). Third-country transfer: data is processed on servers in the USA. Safeguards: EU Standard Contractual Clauses and the EU-US Data Privacy Framework (Adequacy Decision of 10 July 2023). Note that the supervisory authorities point out that the legal certainty gained may only be temporary; previous adequacy regimes (Safe Harbor, Privacy Shield) were invalidated by the CJEU. Data processing agreement: concluded with Google Ireland Ltd. More info:Google Privacy Policy, Browser opt-out.
6.2 Microsoft Clarity
Provider: Microsoft Ireland Operations Ltd., One Microsoft Place, South County Business Park, Leopardstown, Dublin 18, Ireland (parent: Microsoft Corporation, USA). Purpose: Session recordings and heatmaps to improve usability. Note: session recordings are a particularly intensive form of processing — they can capture sensitive content even though input fields are masked by default. We have configured the strictest masking level (‘Strict’) for all form fields. Data: mouse movements, clicks, scroll behaviour, page views, device and browser information, shortened IP address, country. Retention: up to 12 months from the last recorded session. Third-country transfer: Microsoft is a US group; data may be processed on servers in the USA. Safeguards: EU Standard Contractual Clauses and the EU-US Data Privacy Framework. The reservations noted above for GA4 apply analogously. Data processing agreement: Microsoft Online Services DPA concluded. More info:Microsoft Privacy Statement.
6.3 Leadfeeder (Dealfront)
Provider: Dealfront Germany GmbH (Leadfeeder), Markgrafenstraße 36, 10117 Berlin, Germany — EU-based provider. Purpose: B2B identification of visiting companies based on commercially licensed IP-address databases (e.g. RIPE, ARIN, public corporate IP ranges). We use this to inform our sales outreach. The aim is identification of the company, not of an individual user. Important note from a data protection perspective: IP addresses can constitute personal data, particularly when combined with other data. We therefore treat Leadfeeder processing as relevant under GDPR. Data: IP address, page views, timestamp, dwell time, referrer. Data sources: Dealfront enriches IP data with publicly available company information and licensed B2B databases. Retention: up to 12 months on visit level; aggregated reports may be retained longer. Third-country transfer: Dealfront operates primarily on EU infrastructure; sub-processors may include US service providers under EU Standard Contractual Clauses. Data processing agreement: concluded with Dealfront Germany GmbH. More info:Dealfront Privacy Policy.
6.4 Google Ads
Provider: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland (parent: Google LLC, USA). Purpose: We use Google Ads conversion tracking and (where activated) remarketing to measure the success of advertising campaigns and to address visitors with relevant ads. Data: pseudonymous click ID (gclid), conversion event, conversion timestamp, device and browser information. Cookies used include `_gcl_au` (conversion linker) and `test_cookie` (doubleclick.net technical test cookie). Retention: `_gcl_au` up to 90 days, conversion logs in the Google Ads account according to Google retention settings. Third-country transfer: data is processed on Google servers including the USA. Safeguards: EU Standard Contractual Clauses and the EU-US Data Privacy Framework. Data processing agreement: concluded with Google Ireland Ltd. More info:Google Privacy Policy, Ad personalisation settings.
6.5 LinkedIn Insight Tag
Provider: LinkedIn Ireland Unlimited Company, Wilton Plaza, Wilton Place, Dublin 2, Ireland (parent: LinkedIn Corporation, USA). Purpose: The LinkedIn Insight Tag enables campaign measurement, audience analytics and (where activated) retargeting for LinkedIn ad campaigns. Data: IP address (truncated), timestamp, page URL, device characteristics, LinkedIn member ID where the visitor has been logged in to LinkedIn. Cookies used include `bcookie`, `lidc`, `bscookie`. Retention: up to 6 months for direct identifiers; aggregated campaign reports may be retained longer. Third-country transfer: data is processed on LinkedIn servers including the USA. Safeguards: EU Standard Contractual Clauses and the EU-US Data Privacy Framework. Data processing agreement: concluded with LinkedIn Ireland Unlimited Company. More info:LinkedIn Privacy Policy, LinkedIn opt-out.
6.5a Meta Pixel (Facebook Pixel)
Provider: Meta Platforms Ireland Ltd., Merrion Road, Dublin 4, D04 X2K5, Ireland (parent: Meta Platforms, Inc., 1601 Willow Road, Menlo Park, CA 94025, USA). Purpose: The Meta Pixel (also ‘Facebook Pixel’) enables reach measurement, conversion tracking and (where activated) retargeting for advertising campaigns on Facebook and Instagram. It lets us measure the effectiveness of our ads and show relevant advertising to visitors. Data: pseudonymous identifiers, IP address, device and browser information, referrer URL, triggered events (e.g. page view). Cookies used include `_fbp` (first-party cookie used to recognise the browser) and `_fbc` (click identifier derived from the `fbclid` URL parameter). If the visitor was logged in to Facebook / Instagram at the time of the visit, Meta can attribute the visit to the respective account. Joint controllership: for the collection and transmission of the data to Meta there is joint controllership within the meaning of Art. 26 GDPR between us and Meta; we have concluded Meta’s controller addendum for this. Meta is solely responsible for any subsequent processing of the data for its own purposes. Retention: `_fbp` up to 90 days; on the event level according to the retention settings in the Meta Events Manager. Third-country transfer: data is processed on Meta servers including the USA. Safeguards: EU Standard Contractual Clauses and the EU-US Data Privacy Framework (Adequacy Decision of 10 July 2023). The reservations noted above for GA4 apply analogously. Legal basis: your consent pursuant to § 25 (1) TDDDG and Art. 6 (1) (a) GDPR. The pixel is only loaded after you have given consent via our Cookiebot banner. More info:Meta Privacy Policy, Meta ad settings.
6.6 Google Tag Manager
Provider: Google Ireland Limited (see 6.1). Purpose: Google Tag Manager (GTM) is a tag-management system that loads other tracking tags (e.g. Google Analytics, Google Ads, LinkedIn Insight Tag) on this website. GTM itself does not set any cookies and does not collect personal data per se; it only orchestrates the tags loaded after consent. Data: technical request data (IP address, timestamp, user agent) is briefly seen by Google’s GTM-loader server. No persistent identifier is set by GTM itself. Third-country transfer: the GTM loader is hosted on Google infrastructure including the USA. Safeguards as in 6.1. Note: we have configured GTM so that no measurement tag fires before you have given consent via our Cookiebot banner. More info:Google Privacy Policy.
6.7 Cloudflare (CDN & bot management)
Provider: Cloudflare, Inc., 101 Townsend Street, San Francisco, CA 94107, USA, with EU representative Cloudflare Germany GmbH, Rosental 7, c/o Mindspace, 80331 Munich. Purpose: Cloudflare is used by our hosting provider as a Content Delivery Network (CDN) and security layer. The ‘__cf_bm’ cookie is set by Cloudflare’s bot-management to distinguish humans from automated traffic and to mitigate DDoS attacks and content scraping in real time. Why we consider this technically necessary: Without bot-mitigation our website would be vulnerable to credential-stuffing, scraping and DDoS attacks that compromise availability, integrity and the security of the personal data we process (e.g. lead-magnet form submissions, newsletter signups). Bot-mitigation is therefore a technical security measure within the meaning of Art. 32 GDPR (security of processing). Cloudflare itself classifies ‘__cf_bm’ as ‘strictly necessary’ (Cloudflare cookie documentation). Replacing Cloudflare bot-management would weaken the security of personal data on this site. Data: IP address, request headers, technical fingerprint of the request. No persistent identifier across sites. Retention: ‘__cf_bm’ cookie expires after at most 30 minutes of inactivity. Aggregated security logs at Cloudflare are retained briefly under Cloudflare’s standard retention. Legal basis: § 25 (2) Nr. 2 TDDDG (technically required to operate the requested service) and Art. 6 (1) (f) GDPR (overriding legitimate interest in a secure, available website). Third-country transfer: Cloudflare is a US group; data may be processed on servers in the USA. Safeguards: EU Standard Contractual Clauses and the EU-US Data Privacy Framework (Adequacy Decision of 10 July 2023). The EU General Court dismissed the challenge to the adequacy decision on 3 September 2025 (T-553/23). An appeal was filed (C-703/25 P). Data processing agreement: concluded as part of the hosting contract. More info:Cloudflare Privacy Policy.
6.8 Google Search Console
Provider: Google Ireland Limited (see 6.1). Purpose: Google Search Console (GSC) lets us monitor how the site performs in Google’s search results — indexing status, search queries that lead to the site, click-through rates, technical crawl errors. Cookies / tracking on visitors: GSC itself sets no cookies on visitors of this website and runs no client-side script. The site ownership is verified by a static HTML meta tag and / or a DNS TXT record. Data: aggregated search analytics from Google’s side (search queries, impressions, clicks); these are not directly linked to individual visitors. The data is made available to us only in aggregated form. Legal basis: Art. 6 (1) (f) GDPR — legitimate interest in monitoring the site’s search visibility. Third-country transfer: the aggregated reporting is generated on Google infrastructure including the USA. Safeguards as in 6.1. More info:Google Privacy Policy.
6.9 Cookie storage durations
Session cookies are deleted when the browser is closed. Permanent cookies have the following maximum lifetimes: Google Analytics 4 — up to 14 months (data retention shortened to 14 months in GA4 settings); Microsoft Clarity — up to 12 months; Google Ads (`_gcl_au`) — up to 90 days; Meta Pixel (`_fbp`) — up to 90 days; LinkedIn (`bcookie`) — up to 6 months; Cloudflare (`__cf_bm`) — at most 30 minutes of inactivity; Leadfeeder — typically session-based, not stored on the device; CookieConsent (Cookiebot) — up to 12 months from the moment consent is given.
6.10 Withdrawal of consent
You can withdraw your consent at any time with effect for the future — withdrawal is as easy as granting consent:
1. Open cookie settings: click the ‘Cookie settings’ link in the footer to re-open the banner and adjust your choice (this controls all of GA4, Clarity, Google Ads, LinkedIn, Meta Pixel and Leadfeeder). 2. By email: send a short message to info@daniel-herrmann.io — we will block the relevant tools for you. 3. Per tool: for Google Analytics the official browser opt-out is available; for Google Ads under Ad personalisation settings; for LinkedIn under LinkedIn opt-out; for the Meta Pixel under Meta ad settings. Microsoft Clarity and Leadfeeder are controlled exclusively via our cookie banner.
The lawfulness of processing carried out on the basis of consent prior to withdrawal remains unaffected (Art. 7 (3) GDPR).
6.11 Appointment booking with Calendly
We use Calendly LLC, 115 E Main St, Ste A1B, Buford, GA 30518, USA, for appointments on our German booking and compliance check pages. The embedded calendar loads when you explicitly allow preferences, statistics and marketing in our cookie banner. Your choice also applies when you return. You can change it at any time in Cookie settings. You can also arrange an appointment by email or follow the direct link to Calendly, where its own cookie settings apply.
When the calendar loads, Calendly and its service providers receive technical data such as your IP address and browser information. They may use cookies and other browser storage to run the calendar, protect it against abuse, analyse usage and support marketing. Your consent covers optional storage and the associated processing under section 25(1) TDDDG and Article 6(1)(a) GDPR. Under Calendly’s terms, we and Calendly each act as independent controllers for data collected through the embedded cookie technologies.
When you book, we process your name, email address, company, answers to the booking questions and chosen time. We use these details to prepare the meeting and send your Microsoft Teams invitation. The legal basis is Article 6(1)(b) GDPR for steps you request before entering into a contract, or Article 6(1)(f) GDPR for our legitimate interest in responding to a request on behalf of your company. We keep booking details for as long as needed to organise the meeting and handle follow-up correspondence. Statutory retention periods may also apply.
Calendly’s data processing addendum forms part of its customer terms. It covers the booking data Calendly processes on our behalf in the US. For EU-US transfers it provides for the EU-US Data Privacy Framework, with EU standard contractual clauses if that framework ceases to apply. See Calendly’s privacy notice for more information.
7. Web fonts
The fonts used on this website are served locally. Loading these fonts does not connect your browser to Google or any other font provider.
8. Technical and organisational measures (TOM)
To protect your data we implement appropriate technical and organisational measures pursuant to Art. 32 GDPR — among them: TLS encryption (HTTPS) for the entire site, encrypted database connections, server hosting in the EU (Kinsta / GCP Frankfurt), restricted admin access via individual accounts with strong passwords and 2FA, regular automatic backups, role-based access controls, a documented record of processing activities pursuant to Art. 30 GDPR, and data minimisation at the application level. We continuously review and update these measures.
9. Your rights
Under the GDPR you have the following rights:
Right of access (Art. 15 GDPR) — information about which of your personal data we process.
Right to rectification (Art. 16 GDPR) — correction of inaccurate data.
Right to erasure (Art. 17 GDPR) — deletion of your data where the legal conditions are met.
Right to restriction of processing (Art. 18 GDPR).
Right to data portability (Art. 20 GDPR) — receipt of your data in a structured, common, machine-readable format.
Right to object (Art. 21 GDPR) — to processing based on legitimate interest, including for direct marketing. See highlighted box below.
Right to withdraw consent (Art. 7 (3) GDPR) — at any time with effect for the future, see section 6.10.
Right to lodge a complaint (Art. 77 GDPR) — with a supervisory authority, in particular in the EU member state of your residence, your workplace or the location of the alleged infringement. Competent supervisory authority for our office location: Independent Data Protection Centre Saarland (Unabhängiges Datenschutzzentrum Saarland), Fritz-Dobisch-Straße 12, 66111 Saarbrücken.
Requests regarding these rights are to be directed to: info@daniel-herrmann.io. We will respond within the statutory period (usually one month).
10. Currency of this Privacy Policy
Last updated: 22 November 2026. We reserve the right to adapt this policy so that it always meets current legal requirements. The current version is always retrievable from this website.
Free material by email
Your material is on the way.
Enter your name and email, we send the material directly to your inbox, with a short personal note from Daniel.
Thanks, check your inbox.
We just sent the material to your email. If it doesn't arrive within a few minutes, please check your spam folder.
Once a month · CSV practice
CSV insights from real Pharma projects.
What you get next: the GAMP 5 2nd Edition impact, what the FDA CSA Final Guidance means for your validation strategy, and how the 8-week CSV sprint works. Unsubscribe anytime in one click.
Almost done.
Confirm your email via the link we just sent to your inbox. After confirmation we'll send the latest newsletter issue right away.
We use your data exclusively for the newsletter. No sharing with third parties. Privacy policy.